156 related articles for article (PubMed ID: 12393805)
1. New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.
Di Giaimo R; Riccio M; Santi S; Galeotti C; Ambrosetti DC; Melli M
Hum Mol Genet; 2002 Nov; 11(23):2941-50. PubMed ID: 12393805
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum.
Riccio M; Santi S; Dembic M; Di Giaimo R; Cipollini E; Costantino-Ceccarini E; Ambrosetti D; Maraldi NM; Melli M
Neurobiol Dis; 2005 Oct; 20(1):104-14. PubMed ID: 16137571
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1).
Riccio M; Di Giaimo R; Pianetti S; Palmieri PP; Melli M; Santi S
Exp Cell Res; 2001 Jan; 262(2):84-94. PubMed ID: 11139332
[TBL] [Abstract][Full Text] [Related]
4. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations.
Alakurtti K; Weber E; Rinne R; Theil G; de Haan GJ; Lindhout D; Salmikangas P; Saukko P; Lahtinen U; Lehesjoki AE
Eur J Hum Genet; 2005 Feb; 13(2):208-15. PubMed ID: 15483648
[TBL] [Abstract][Full Text] [Related]
5. Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo.
Cipollini E; Riccio M; Di Giaimo R; Dal Piaz F; Pulice G; Catania S; Caldarelli I; Dembic M; Santi S; Melli M
Biochim Biophys Acta; 2008 Feb; 1783(2):312-22. PubMed ID: 17920138
[TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
de Haan GJ; Halley DJ; Deelen WH; Lindhout D
Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
[TBL] [Abstract][Full Text] [Related]
7. Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1.
Lehtinen MK; Tegelberg S; Schipper H; Su H; Zukor H; Manninen O; Kopra O; Joensuu T; Hakala P; Bonni A; Lehesjoki AE
J Neurosci; 2009 May; 29(18):5910-5. PubMed ID: 19420257
[TBL] [Abstract][Full Text] [Related]
8. Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1).
Singh S; Plotnikova L; Karvonen K; Ryytty S; Hyppönen J; Kälviäinen R; Hämäläinen RH
Stem Cell Res; 2023 Dec; 73():103248. PubMed ID: 37951142
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1).
Houseweart MK; Vilaythong A; Yin XM; Turk B; Noebels JL; Myers RM
Cell Death Differ; 2003 Dec; 10(12):1329-35. PubMed ID: 12934064
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy.
Kaur G; Mohan P; Pawlik M; DeRosa S; Fajiculay J; Che S; Grubb A; Ginsberg SD; Nixon RA; Levy E
Am J Pathol; 2010 Nov; 177(5):2256-67. PubMed ID: 20889561
[TBL] [Abstract][Full Text] [Related]
11. Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation.
Joensuu T; Tegelberg S; Reinmaa E; Segerstråle M; Hakala P; Pehkonen H; Korpi ER; Tyynelä J; Taira T; Hovatta I; Kopra O; Lehesjoki AE
PLoS One; 2014; 9(2):e89321. PubMed ID: 24586687
[TBL] [Abstract][Full Text] [Related]
12. Seizures induce widespread upregulation of cystatin B, the gene mutated in progressive myoclonus epilepsy, in rat forebrain neurons.
D'Amato E; Kokaia Z; Nanobashvili A; Reeben M; Lehesjoki AE; Saarma M; Lindvall O
Eur J Neurosci; 2000 May; 12(5):1687-95. PubMed ID: 10792446
[TBL] [Abstract][Full Text] [Related]
13. Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy.
Arbatova J; D'Amato E; Vaarmann A; Zharkovsky A; Reeben M
Epilepsia; 2005; 46 Suppl 5():49-51. PubMed ID: 15987253
[TBL] [Abstract][Full Text] [Related]
14. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
Pennacchio LA; Bouley DM; Higgins KM; Scott MP; Noebels JL; Myers RM
Nat Genet; 1998 Nov; 20(3):251-8. PubMed ID: 9806543
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of the mouse cystatin B gene.
Pennacchio LA; Myers RM
Genome Res; 1996 Nov; 6(11):1103-9. PubMed ID: 8938434
[TBL] [Abstract][Full Text] [Related]
16. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).
Lalioti MD; Mirotsou M; Buresi C; Peitsch MC; Rossier C; Ouazzani R; Baldy-Moulinier M; Bottani A; Malafosse A; Antonarakis SE
Am J Hum Genet; 1997 Feb; 60(2):342-51. PubMed ID: 9012407
[TBL] [Abstract][Full Text] [Related]
18. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.
Vaarmann A; Kaasik A; Zharkovsky A
Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687
[TBL] [Abstract][Full Text] [Related]
19. The epilepsy, the protease inhibitor and the dodecamer: progressive myoclonus epilepsy, cystatin b and a 12-mer repeat expansion.
Lalioti MD; Antonarakis SE; Scott HS
Cytogenet Genome Res; 2003; 100(1-4):213-23. PubMed ID: 14526183
[TBL] [Abstract][Full Text] [Related]
20. Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1.
Lalioti MD; Scott HS; Antonarakis SE
Hum Mol Genet; 1999 Sep; 8(9):1791-8. PubMed ID: 10441345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
